People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Other Technology, Healthtech, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mindstrong, Inc. | — | Other Technology | Series B | $52.0M | $944.1M | 2018 |
| Vanna Health, Inc. | — | Healthtech | Series B | $35.0M | $25.4M | 2022 |
| Neurawell Therapeutics, Inc. | — | Pharma | Seed | $1.6M | $8.2M | 2024 |
Tom Insel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tom Insel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hemant Taneja | 1 | 21 |
| Robert Epstein | 1 | 8 |
| Jack Abraham | 1 | 8 |
| Richard Klausner | 1 | 7 |
| Steve Shulman | 1 | 5 |
| Giovanni Colella | 1 | 4 |
| Jim Kim | 1 | 4 |
| Jim Tananbaum | 1 | 4 |
| Sarah London | 1 | 3 |
| Magid Abraham | 1 | 3 |
| Martha Temple | 1 | 3 |
| Steve Klasko | 1 | 1 |
| Paul Dagum | 1 | 1 |
| Brian Meewes | 1 | 1 |
| Jessie Mitchell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.